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Background: Four-dimensional (4D) flow cardiovascular magnetic 
resonance imaging (MRI) is an emerging technique used for intra-
cardiac blood flow assessment. The role of 4D flow cardiovascular MRI 
in the assessment of trans-valvular flow in patients with atrial 
fibrillation (AF) has not previously been assessed. The purpose of this 
study was to assess the feasibility, image quality, and internal validity 
of 4D flow cardiovascular MRI in the quantification of trans-valvular 
flow in patients with AF. 
Methods: Patients with AF and healthy controls in sinus rhythm 
underwent cardiovascular MRI, including 4D flow studies. Quality 
assurance checks were done on the raw data and streamlines. 
Consistency was investigated by trans-valvular flow assessment 
between the mitral valve (MV) and the aortic valve (AV). 
Results: Eight patients with AF (88% male, mean age 62±13 years, 
mean heart rate (HR) 83±16 beats per minute (bpm)) were included 
and compared with ten healthy controls (70% male, mean age 41±20 
years, mean HR 68.5±9 bpm). All scans were of either good quality 
with minimal blurring artefacts, or excellent quality with no artefacts. 
No significant bias was observed between the AV and MV stroke 
volumes in either healthy controls (–4.8, 95% CI –15.64 to 6.04; P=0.34) 
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or in patients with AF (1.64, 95% CI –4.7 to 7.94; P=0.56). A significant 
correlation was demonstrated between MV and AV stroke volumes in 
both healthy controls (r=0.87, 95% CI 0.52 to 0.97; P=0.001) and in AF 
patients (r=0.82, 95% CI 0.26 to 0.97; P=0.01). 
Conclusions: In patients with AF, 4D flow cardiovascular MRI is 
feasible with good image quality, allowing for quantification of trans-
valvular flow.
Keywords 
4D flow CMR, Haemodynamics, Flow quantification, Validation, Atrial 
fibrillation
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Introduction
Atrial fibrillation (AF) is the most common sustained cardiac 
rhythm disturbance in adults1. Recent data suggest the preva-
lence of AF is between 2% and 4% worldwide1, with this figure 
expected to rise2,3. Whilst AF can occur in individuals without 
other cardiovascular comorbidities, it is frequently associated 
with cardiac disease, including heart failure (with reduced and 
preserved ejection fraction), valvular disease, and ischaemic 
heart disease. Cardiovascular magnetic resonance imaging (MRI) 
is assuming a prominent role in the management of patients 
with AF, both in the assessment of atrial substrate in the 
pre-ablation setting4 and in those with associated cardiovascular 
conditions with concomitant AF5.
Four-dimensional flow (4D flow) cardiovascular MRI is an 
emerging technique used for intra-cardiac blood flow assess-
ment in the research and clinical setting. Previous studies have 
demonstrated accurate and reliable assessment of valvular 
flow and regurgitation quantification using retrospective valve 
tracking methods6,7. Furthermore, 4D flow-derived valvular flow 
assessment circumvents issues with Doppler-based echocar-
diography measurements and two-dimensional phase-contrast 
(PC) acquisition cardiovascular MRI8. As with most cardiovas-
cular MRI techniques, 4D flow traditionally requires cardiac 
gating using electrocardiography (ECG) in order to depict the 
various cardiac structures and movements. Cardiac rhythms 
with high R-R interval variability such as AF can result in 
significant image quality degradation and challenging image 
analyses. As a result, the feasibility, precision, and reliability 
of valvular flow quantification in patients with AF have not 
previously been assessed.
We hypothesised that 4D flow cardiovascular MRI is feasi-
ble in patients with AF and can accurately and consistently 
quantify valvular flow. The aims of this study were to (i) assess 
the feasibility of acquiring 4D flow MRI in patients with AF 
and (ii) investigate the consistency and reliability of retrospec-
tive valve tracking in the quantification of aortic and mitral 




The study protocol was approved by the National Research 
Ethics Service (12/YH/0169) in the UK. The study was 
approved by the local ethics committee and complied with the 
Declaration of Helsinki. All patients gave written informed 
consent immediately prior to MRI examinations.
Study design and population
This was an observational cross-sectional study. In order to 
assess for internal validity, a healthy cohort was used as a 
comparator. For the study group, we recruited eight patients 
with persistent AF from the cardiology department at Leeds 
Teaching Hospitals NHS Trust. Patients were approached 
during either hospital admission or outpatient clinic review. 
Inclusion criteria included patients over the age of 18 years 
old with AF and a stable heart rate between 70 to 110 beats 
per minute; the only exclusion criterion was contraindica-
tion to MRI. For the healthy control group, another cohort of 
volunteers in normal sinus rhythm with no previous cardio-
vascular disorders were recruited. Controls were approached 
through an appeal for healthy volunteers via the University 
of Leeds and were not matched to AF cases. As the purpose 
of the study was to determine feasibility of 4D flow cardiovas-
cular MRI in AF, power calculations were not performed to 
determine sample size.
Cardiovascular MRI. All patients underwent cardiovascular 
MRI on a 1.5 Tesla system (Ingenia, Philips, Best, The 
Netherlands), with a 28-channel flexible torso coil, with digiti-
sation of the MR signal in the receiver coil, at the University of 
Leeds between January 2014 and December 2017. As previously 
described9,10, the cardiovascular MRI protocol included baseline 
survey, cine imaging (vertical long axis, horizontal long axis, 
short-axis contiguous left-ventricle volume stack) acquired 
using balanced steady-state free precession in a single slice 
breath-hold sequence, and whole heart 4D flow acquired 
using a fast field echo pulse sequence (echo-planar imaging 
[EPI] based with sensitivity encoding [SENSE] acceleration) 
with retrospective ECG triggering. Typical 4D image param-
eters were as follows: EPI acceleration factor of 5 and SENSE 
factor of 2, flip angle 10°, velocity encoding 150 cm/s, field of 
view 400 mm, echo time 3.5 ms, repetition time 10 ms, 90% par-
tial k-space coverage in phase-encoding directions, number of 
signal averages 1; images were acquired during free breathing; 
the number of slices was 35–40, with a temporal resolution 
of 40 ms; the reconstructed number of phases was 3010.
Image analysis. Image analysis was performed offline using 
MASS software (Version 2018EXP, Leiden University Medi-
cal Centre, Leiden, The Netherlands). Similar types of analysis 
can be carried out by open source software packages like 
FourFlow. All images were analysed by an imaging cardi-
ologist (PG) with more than five years’ experience working 
with 4D flow cardiovascular MRI. Left ventricular volumes 
and ejection fraction were calculated from cine images using 
standard methods11: endocardial and epicardial contours were 
traced on the left ventricular and right ventricular cine stack at 
end-systole and end-diastole to determine end systolic volume, 
end diastolic volume, stroke volume, ejection fraction and 
left ventricular mass. Volumes were indexed to body surface area. 
For each 4D flow data set, a visual quality assessment on the 
          Amendments from Version 1
In this revised version, we address the reviewers’ feedback and 
comments. This includes minor changes to Figure 1, Figure 2 





Page 3 of 16
Wellcome Open Research 2021, 6:73 Last updated: 22 JUN 2021
phase contrast and magnitude images was performed to deter-
mine image quality and presence of artefact, and scored on a 
4-point scale9,10: 0, excellent quality without artefacts; 1, 
good quality with mild blurring artefacts; 2, moderate qual-
ity with moderate blurring artefacts; 3, poor quality with severe 
artefacts leading to non-evaluable data.
Flow and velocity measurement. Contour segmentation was 
performed manually. 4D flow assessments were performed 
using validated techniques including retrospective valve track-
ing, with measurement planes located perpendicular to the 
inflow direction on two- and four-chamber cines10,12 (Figure 1). 
Background velocity corrections were performed from the 
velocity sampled in the myocardium and phase unwrap-
ping was undertaken on source images if aliasing occurred 
within in the area of interest, as per our previous work10,13–16. 
Trans-valvular forward flow and regurgitant flow were meas-
ured over the entire cardiac cycle for both the mitral and the 
aortic valve from the reconstructed dynamic phase-contrast plane. 
Trans-valvular stroke volume across the aortic valve (AV) and 
mitral valve (MV) was calculated as the difference between 
absolute forward flow and regurgitant flow through each valve 
(Figure 1). In patients with AF, trans-valvular flow was 
measured as the average of velocities over 10 to 12 heart beats 
in order to remove beat-to-beat variability. Through-plane 
myocardial motion was accounted for in the above calculations.
Statistical analysis. Statistical analysis was performed using 
MedCalc Version 19.6.3. Continuous variables are expressed 
as mean ± standard deviation and categorical variables as num-
bers and percentages. Data was treated as normally distributed. 
Demographic comparisons were performed using an independ-
ent samples t-test. Student t-test was used to compare paired 
data. Bland-Altman plots were used to visually assess the 
agreement between methods and investigate absolute bias. Cor-
relation assessment between AV and MV transvalvular stroke 
volumes was performed using Pearson’s correlation coefficient 




Eight patients with AF were included and compared with ten 
healthy controls in sinus rhythm17. Baseline demographics are 
detailed in Table 1. Seven (88%) of the AF patients were male 
and the mean age was 62 ± 13 years. Age, body mass index, 
and heart rate were significantly higher in patients with AF than 
healthy controls.
Image quality assessment
All scans were of either good quality with minimal blurring 
artefacts, or excellent quality with no artefacts (grade 1 and 0, 
respectively).
Baseline cardiovascular MR scan parameters
Baseline cardiovascular MR scan parameters are summarised 
in Table 2. Left ventricular end-systolic volumes (LV-ESV) 
were significantly higher in patients with AF compared to 
Figure 1. A case example of a patient in atrial fibrillation demonstrating two-dimensional velocity vectors superimposed over cine images 
(a), and an example of segmentation of valvular flow contours on the phase contrast multiplanar reconstruction alongside mitral valve 
stroke volumes (SV) (b) and aortic valve SV (c).
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healthy controls (LV-ESV AF: 133 ± 42 ml, control: 59 ± 15 ml; 
P < 0.01). Left ventricular stroke volume (LV-SV) and ejec-







Age (years) 41±20 62±13 0.02
Sex (female) 3 1 0.4
Weight (kg) 72±12 94±16 <0.01
Height (cm) 170±8 174±10 0.32
Body mass index (kg/m2) 25±2 31±5 <0.01
Heart rate (bpm) 68.5±9 83±16 0.03
Smoker (n) 0 3 0.02
Hypertension (n) 0 3 0.02
Hypercholesterolaemia (n) 0 1 0.24







LV-EDV (ml) 155±39 202±39 0.02
LV-ESV (ml) 59±15 133±42 <0.01
LV-SV (ml) 97±29 69±20 0.03
LV-EF (%) 62±6 35±9 <0.01
LV-EDM (g) 94±24 129±30 0.01
LV-ESM (g) 96±25 134±30 0.01
LV-EDVi (ml/m2) 84±16 95±20 0.18
LV-ESVi (ml/m2) 32±7 63±21 <0.01
LV-SVi (ml/m2) 52±12 32±9 <0.01
LV-EDMi (g/m2) 50±10 61±13 0.06
MV SV (ml) 73±26 53±12 0.06
MR volume (ml) 0±0 6±6 <0.01
AV SV (ml) 78±30 51±13 0.04
Abbreviations: AV, aortic valve; EDM, end-diastolic mass; EDV, end-diastolic 
volume; EF, ejection fraction; ESM, end-systolic mass; ESV, end-systolic 
volume; LV, left ventricular; MV, mitral valve; MR, mitral regurgitant; SV, 
stroke volume. The suffix i represents indexed values to body surface area.
(LV-SV AF: 69 ± 20 ml, control: 97 ± 29 ml; P = 0.03; LV-EF 
AF: 35 ± 9%, control: 62 ± 6%; P < 0.01). AV stroke volumes 
were significantly lower in AF patients (AF: 51 ±13 ml, control: 
78 ±30 ml; P=0.04); MV stroke volume was also lower in 
those with AF, but this did not meet statistical significance 
(AF: 53 ±12 ml, control: 73 ±26 ml; P=0.06). Patients with 
AF had a mitral regurgitant volume of 6 ±6 ml; none of the 
healthy controls had mitral regurgitation.
Consistency in 4D flow derived valvular stroke volumes
There was no significant difference in MV and AV stroke volumes 
in healthy controls (72.85 ± 25.87 ml vs. 77.65 ± 30.45 ml 
respectively; P=0.34) or in patients with AF (52.92 ± 11.8 ml 
vs. 51.29 ± 12.86 ml; P=0.56) (Figure 2). MV forward flow, 
regurgitant flow and stroke volume for individual AF patients 
are detailed in Figure 3. In both AF patients and controls, the 
mean MV and AV stroke volumes were compared with the 
difference between MV and AV stroke volumes by Bland- 
Altman analysis (Figure 4). No significant bias was observed, 
although bias was higher in healthy controls (–4.8, 95% 
CI –15.64 to 6.04; P=0.34) than in patients with AF (1.64, 95% 
CI –4.7 to 7.94; P=0.56). There was a strong correlation between 
MV and AV stroke volumes in healthy controls (Pearson’s 
correlation r = 0.87, 95% CI 0.52 to 0.97; P=0.0011) and AF 
patients (r = 0.82, 95% CI 0.26 to 0.97; P=0.0134) (Figure 5).
Discussion
This study investigated the feasibility of performing 4D flow 
cardiovascular MRI in patients with AF for the accurate 
assessment of trans-valvular flow. We demonstrated that 4D flow 
cardiovascular MRI is feasible in patients with rate-controlled 
AF, and that it allows accurate quantification of trans-valvular 
flow and regurgitation in patients with AF. 
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Figure 2. Mitral and aortic valve stroke volumes in healthy controls and patients with atrial fibrillation.
Figure 3. Mitral valve (MV) forward flow, regurgitant flow and stroke volume for individual patients with atrial fibrillation.
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Figure 5. Pearson correlation (r) between mitral valve (MV) stroke volume (SV) and aortic valve (AV) SV in healthy controls and 
patients with atrial fibrillation. The shaded areas represent 95% confidence intervals.
Figure 4. Bland-Altman plot of the mean of mitral valve (MV) and aortic valve (AV) stroke volumes (SV) in healthy control and 
patients with atrial fibrillation.
Page 7 of 16
Wellcome Open Research 2021, 6:73 Last updated: 22 JUN 2021
Known applications of 4D flow cardiovascular MRI in AF
Previous research applications of 4D flow cardiovascular MRI 
in patients with AF are limited and include the assessment of 
left atrial (LA) flow and stasis18–23, the assessment of LA and 
LV function following cardioversion18,24, and the effect of AF 
on aortic flow25. Kim et al. observed that LV stroke volume and 
components of LV flow (including delayed ejection, retained 
inflow, and residual volume) were significantly different between 
patients with paroxysmal AF (in sinus rhythm at the time of 
4D flow cardiovascular MRI) and healthy controls26, suggesting 
that the substrate leading to AF in itself may lead to LV flow 
impairment, rather than the rhythm disturbance alone.
Quantitative assessment of trans-valvular stroke 
volume
No previous 4D flow cardiovascular MRI studies have exam-
ined the assessment of trans-valvular flow in patients with AF. 
In order to ensure the appropriate application of 4D flow 
cardiovascular MRI in patients with AF in both the research 
and clinical settings, the validity, accuracy, and reliability of 
trans-valvular flow measurements are fundamental. Our study 
demonstrates that there is no significant bias between AV and 
MV stroke volumes in patients with AF, similar to healthy 
controls, and found a strong correlation between MV and AV stroke 
volumes in both groups. As no reference method for MV or AV 
trans-valvular stroke volumes exists in patients with AF, we 
used a mean of both measurements when examining for agree-
ment between measurements (Figure 4). In echocardiography 
studies, the optimal mean number of beats required to 
estimate AV flow and cardiac output in AF is 13 beats (with 
a range of 4 to 17) to achieve a variability of less than 2%, 
compared to a mean of 4 beats in sinus rhythm27,28. Similarly, we 
measured trans-valvular flow as the average of velocities over 
many heart beats, in order to remove beat-to-beat variability. 
4D flow MRI may therefore have an advantage to quantify 
transvalvular flow in atrial fibrillation. We noticed that the 
LV stroke volume from cine segmentation were higher in both 
the healthy and AF cohorts when compared to respective mitral 
and aortic flows. We suspect this is mainly due to variation 
of basal slice segmentation on cine, as it is well known that 
slight variations in basal segmentation of endocardium can 
result in significant differences in stroke volume.
Quantitative assessment of mitral regurgitation
Mitral regurgitation remains a common clinical entity in 
patients with AF. The superiority of cardiovascular MRI in the 
quantitative evaluation of mitral regurgitant volume in compari-
son with 2-dimensional echocardiography is well established29,30. 
Our data highlights the precision with which 4D flow cardio-
vascular MRI is able to calculate mitral regurgitant volume in 
AF, within 3–4 ml (Figure 3). This allows the severity of mitral 
regurgitation to be graded with incredible accuracy compared 
with echocardiography. These findings warrant investigation 
in larger cohorts.
Limitations
The number of patients with AF included in this study was 
low. However, the key findings were based on intra-group 
comparisons showing internal validity. Secondly, we recruited 
patients with rate-controlled AF and in stable conditions. The 
results of this study cannot therefore be extrapolated to patients 
in AF with a ventricular rate greater than 110bpm. Third, 
patients underwent a single scan only, without longitudinal 
follow-up. Given previous evidence of physiological variability 
over time in patients with AF31, a temporal assessment would be 
beneficial.
Conclusion
Whole-heart, 4D flow cardiovascular MRI is feasible in patients 




Access to the raw images of patients is not permitted since 
specialised post-processing imaging-based solutions can identify 
the study patients in the future.
Harvard Dataverse: Feasibility and validation of trans-valvular 
flow derived by four-dimensional flow cardiovascular magnetic 
resonance imaging in patients with atrial fibrillation. 
https://doi.org/10.7910/DVN/YHDLIT17.
This project contains the following underlying data:
-  Data for repository.tab (spreadsheet demographic and 
outcome variables)
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
Consent
All patients gave written informed consent prior to MRI 
examinations.
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involved in acquisition and analysis, as well as data interpretation. 
R.J.v.d.G. assisted with the conception and design of the 
study, in addition to developing the methods for the study and 
proving the software for analysis. S.P. supervised the study. 
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critical input in methodology, drafting of the manuscript and 
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a complex cohort for obtaining cardiac images such as in patients with atrial fibrillation.  
 
Introduction: 
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Materials & methods and results: 
Well presented and detailed. Image analysis methodology clearly displayed. Graphics and results 
help to explain the main objective of the study.  
 
Minor comment: The AV and MV abbreviations are defined in the abstract but should be defined in 
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Well-conducted. Comprehensive exposure of the limitations. Conclusion well presented.  
 
Tables: 
Well balanced with clear information and adequate regarding the objectives stated in the study. 
 
Images: 
Figure 1a. The only comment I have with this figure is that the large amount of images in it makes 
difficult to visualize the great quality of the 4D flow images. I would suggest to reduce the number 
of images included in figure 1a.
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